Browse By: Country ι Category ι Publisher ι Tag
Home  »  Pharmaceutical

Pharmaceutical Market Research Reports

The global pharmaceutical market is almost a trillion dollar industry. The pharmaceutical market has been playing a very important role in the area of scientific advancement and has contributed significantly to economic growth all across the globe. The global pharmaceutical market consists of a wide range of mid-sized, and big companies, and multinational corporations like biopharmaceutical firms, pharmaceutical companies, virtual pharmas, generic manufacturer
biotechnology firms. The pharmaceutical market also includes various service and ancillary support firms which provide raw materials, undertake contract research projects, contract sales, manufacturing technologies, and regulatory guidance. 


The global pharmaceutical market is witnessing satisfactory growth owing to factors like high incidence of chronic and contagious diseases, and rising life expectancy. Research and development related investments are also taking place in the pharmaceutical market due to rising demand for innovative and better drugs. An emerging segment in the pharmaceutical market is that of biopharmaceuticals which is extensively applied in proteomics, drug discovery, and genomics. 


The highest market share in the global pharmaceutical market is held by the US. It is expected that emerging economies of the Asia Pacific like India and China will report high rates of growth in the forthcoming years. This is because huge pharmaceutical companies these days are outsourcing their R&D projects to these economies for better cost efficiency and to efficiently utilize the scientific labor pool in these economies. 


The growth of the global pharmaceutical market gets affected due to regulatory measures, price pressures, and high demand for innovative drugs, short product lifecycles, and weak drug pipelines. 


Marketresearchreports.biz provides thousands of detailed and exhaustive market research reports on the global pharmaceutical market that add immense value to your vital business strategies and decisions. These reports contain accurate data and facts that enable you to take the right business decision.

More

Ocular Pain-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Anesthetic Effect-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Chronic Lymphocytic Leukemia (CLL)-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Vulvovaginal Candidiasis-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Indigestion-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Seborrhea-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Skin And Soft Tissue Infections-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Staphylococcal Infections-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Myocardial Infarction-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Gram-Negative Bacterial Infections-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Anxiety Disorders-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Reflux Esophagitis (Gastroesophageal Reflux Disease)-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Benign Prostatic Hyperplasia-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Peptic Ulcers-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Type 1 Diabetes (Juvenile Diabetes)-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Respiratory Tract Infections-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Breast Cancer-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Lymphoma-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Epilepsy-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Acquired (Autoimmune) Hemolytic Anemia-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
HIV/AIDS-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Post-Operative Pain-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Esophagitis-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Neuropathic Pain-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia)-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Hypercholesterolemia-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Cellulitis-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Metastatic Prostate Cancer-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: DelveInsight

Price: $1250
Obsessive-Compulsive Disorder-API Insights, 2014
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positione
Published Date: Nov 2014
Published By: Daedal Research

Price: $1250
Global Spine Market Report: 2014 Edition
Spine market is the largest segment of the global orthopedic industry. Spine disorders are categorized in four sections: degenerative conditions, deformities, tumor and trauma-based disorders. Spinal implants include both fusion and non-fusion devices: devices associated with vertebral compression fracture (VCF), interbody devices, cervical, thoracolumbar, and spinal stimulation devices. Spine industry has witnessed myriad technological advancements over the past two decades and it is expected that this trend will continue in future to solve the present challenges and fill the unmet needs of the market. It is expected that new innovations in the field of minimally invasive surgeries will continue to have a positive impact on the market as the new and improved surgical tool will make c
Published Date: Nov 2014
Published By: Koncept Analytics

Price: $800
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023
EpiCast Report: Celiac Disease - Epidemiology Forecast to 2023SummaryCeliac disease is an autoimmune disease that occurs in individuals who consume gluten-containing foods but are intolerant to gluten, a protein found in many grains, such as wheat, rye, and barley. In celiac disease, the bodys immune system attacks and destroys the villi of the small intestine and thus interferes with nutrient absorption. Celiac disease can be difficult to diagnose because the symptoms vary between individuals and are non-specific, such as abdominal bloating and pain, diarrhea, constipation, and weight loss. Short-term malicious effects of untreated celiac disease include malnutrition, vitamin and mineral deficiency, and anemia, whereas long-term effects include bone diseases, cancers, and liver diseases.
Published Date: Nov 2014
Published By: GlobalData

Price: $3995
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy
PharmaSphere: Emerging Biotechnologies - Stem Cell TherapySummaryGlobalDatas report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells industry. It discusses key development trends, regulatory requirements in various markets, recent deals activity and industry dynamic trends, as well as describes the operations strategy of these companies. Furthermore, it includes a geographical segmentation of various markets including the EU and US, as well as emerging markets such as China, India, SouthKorea, and Israel-providing in-depth analysis of these markets regulatory framework, key domestic players and their stem cell pipelines, and strategic outlook.Throughout the report, GlobalDatas analysts provide you with expert insight, expand
Published Date: Nov 2014
Published By: GlobalData

Price: $2995
Bullous Pemphigoid Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Bullous Pemphigoid Global Clinical Trials Review, H2, 2014" provides data on the Bullous Pemphigoid clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bullous Pemphigoid. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bullous Pemphigoid. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Chediak-Higashi Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chediak-Higashi Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chediak-Higashi Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014" provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for tre
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Churg-Strauss Syndrome Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Churg-Strauss Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Churg-Strauss Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Churg-Strauss Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Churg-Strauss Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Cutaneous Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on the Cutaneous Lupus Erythematosus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cutaneous Lupus Erythematosus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cutaneous Lupus Erythematosus. This report is built using data and information sourced from proprietary databases, primary and secondary research a
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Ebola Viral Infections Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Ebola Viral Infections Global Clinical Trials Review, H2, 2014" provides data on the Ebola Viral Infections clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ebola Viral Infections. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ebola Viral Infections. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Food Allergy Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Food Allergy Global Clinical Trials Review, H2, 2014" provides data on the Food Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Food Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Food Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Sc
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Grass Pollen Allergy Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Grass Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Grass Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Grass Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Grass Pollen Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2014
Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2014" provides data on the Graft Versus Host Disease (GVHD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Graft Versus Host Disease (GVHD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Graft Versus Host Disease (GVHD). This report is built using da
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Hashimotos Thyroiditis Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Hashimoto's Thyroiditis Global Clinical Trials Review, H2, 2014" provides data on the Hashimotos Thyroiditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hashimotos Thyroiditis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hashimotos Thyroiditis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glo
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Graves Diseases Global Clinical Trials Review, H2, 2014
Graves Diseases Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Graves Diseases Global Clinical Trials Review, H2, 2014" provides data on the Graves Diseases clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Graves Diseases. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Graves Diseases. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
House Dust Mite Allergy Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, House Dust Mite Allergy Global Clinical Trials Review, H2, 2014" provides data on the House Dust Mite Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on House Dust Mite Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating House Dust Mite Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Mild Psoriasis Global Clinical Trials Review, H2, 2014
Mild Psoriasis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Mild Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Mild Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mild Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mild Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Kawasaki Disease Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Kawasaki Disease Global Clinical Trials Review, H2, 2014" provides data on the Kawasaki Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Kawasaki Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Kawasaki Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industr
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Moderate Psoriasis Global Clinical Trials Review, H2, 2014
Moderate Psoriasis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Moderate Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Moderate Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Moderate Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Moderate Psoriasis. This report is built using data and information sourced from proprietary databases, primary and sec
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014" provides data on the Lambert-Eaton Myasthenic Syndrome (LEMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lambert-Eaton Myasthenic Syndrome (LEMS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lambert-Eaton Myasthenic Syndrome (LEMS). This report is built using data and information sourced from proprietary
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Peanut Allergy Global Clinical Trials Review, H2, 2014
Peanut Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Peanut Allergy Global Clinical Trials Review, H2, 2014" provides data on the Peanut Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Peanut Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Peanut Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Acute Lung Injury Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Acute Lung Injury Global Clinical Trials Review, H2, 2014" provides data on the Acute Lung Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Lung Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Lung Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of ind
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Pemphigus Global Clinical Trials Review, H2, 2014
Pemphigus Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Pemphigus Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pemphigus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pemphigus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Glob
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Multiple Myeloma (Kahlers Disease) Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Multiple Myeloma (Kahler's Disease) Global Clinical Trials Review, H2, 2014" provides data on the Multiple Myeloma (Kahlers Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Multiple Myeloma (Kahlers Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Multiple Myeloma (Kahlers Disease). This report is built using data and information sourced from proprietary databases, primary and
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014
Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Pemphigus Vulgaris Global Clinical Trials Review, H2, 2014" provides data on the Pemphigus Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pemphigus Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pemphigus Vulgaris. This report is built using data and information sourced from proprietary databases, primary and sec
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Relapsed Multiple Myeloma Global Clinical Trials Review, H2, 2014" provides data on the Relapsed Multiple Myeloma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsed Multiple Myeloma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Relapsed Multiple Myeloma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house anal
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014
Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Plaque Psoriasis (Psoriasis Vulgaris) Global Clinical Trials Review, H2, 2014" provides data on the Plaque Psoriasis (Psoriasis Vulgaris) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Plaque Psoriasis (Psoriasis Vulgaris). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Plaque Psoriasis (Psoriasis Vulgaris). This
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Refractory Multiple Myeloma Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Refractory Multiple Myeloma Global Clinical Trials Review, H2, 2014" provides data on the Refractory Multiple Myeloma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Refractory Multiple Myeloma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Refractory Multiple Myeloma. This report is built using data and information sourced from proprietary databases, primary and secondary research and i
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Pollen Allergy Global Clinical Trials Review, H2, 2014
Pollen Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Pollen Allergy Global Clinical Trials Review, H2, 2014" provides data on the Pollen Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pollen Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pollen Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Hypersensitivity Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hypersensitivity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industr
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Ragweed Allergy Global Clinical Trials Review, H2, 2014
Ragweed Allergy Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Ragweed Allergy Global Clinical Trials Review, H2, 2014" provides data on the Ragweed Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ragweed Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ragweed Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014" provides data on the Juvenile Rheumatoid Arthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Juvenile Rheumatoid Arthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Juvenile Rheumatoid Arthritis. This report is built using data and information sourced from proprietary databases, primary and secondary research a
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014
Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Rheumatoid Arthritis Global Clinical Trials Review, H2, 2014" provides data on the Rheumatoid Arthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rheumatoid Arthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Rheumatoid Arthritis. This report is built using data and information sourced from proprietary databases, prima
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Lung Transplantation Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Lung Transplantation Global Clinical Trials Review, H2, 2014" provides data on the Lung Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lung Transplantation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lung Transplantation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Severe Psoriasis Global Clinical Trials Review, H2, 2014
Severe Psoriasis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Severe Psoriasis Global Clinical Trials Review, H2, 2014" provides data on the Severe Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Severe Psoriasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Severe Psoriasis. This report is built using data and information sourced from proprietary databases, primary and secondary res
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Lupus Erythematosus Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on the Lupus Erythematosus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Erythematosus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lupus Erythematosus. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's tea
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Spondylitis Global Clinical Trials Review, H2, 2014
Spondylitis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Spondylitis Global Clinical Trials Review, H2, 2014" provides data on the Spondylitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spondylitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spondylitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analys
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Milk Allergy Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Milk Allergy Global Clinical Trials Review, H2, 2014" provides data on the Milk Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Milk Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Milk Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Sc
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014" provides data on the Systemic Lupus Erythematosus clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Systemic Lupus Erythematosus. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Systemic Lupus Erythematosus. This report is built using data and information s
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Bone Marrow Transplantation Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Bone Marrow Transplantation Global Clinical Trials Review, H2, 2014" provides data on the Bone Marrow Transplantation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bone Marrow Transplantation. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Bone Marrow Transplantation. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-ho
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Type I hypersensitivity Global Clinical Trials Review, H2, 2014
Type I hypersensitivity Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Type I hypersensitivity Global Clinical Trials Review, H2, 2014" provides data on the Type I hypersensitivity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Type I hypersensitivity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Type I hypersensitivity. This report is built using data and information sourced from proprietary d
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Degenerative Osteoarthritis Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Degenerative Osteoarthritis Global Clinical Trials Review, H2, 2014" provides data on the Degenerative Osteoarthritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Osteoarthritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Osteoarthritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-ho
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2014
Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Von Hippel-Lindau Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Von Hippel-Lindau Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Von Hippel-Lindau Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Von Hippel-Lindau Syndrome. This report is built using data and information sourced fro
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014
GlobalData's clinical trial report, Familial Mediterranean Fever Global Clinical Trials Review, H2, 2014" provides data on the Familial Mediterranean Fever clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Familial Mediterranean Fever. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Familial Mediterranean Fever. This report is built using data and information sourced from proprietary databases, primary and secondary research and i
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014
Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Wegener's Granulomatosis Global Clinical Trials Review, H2, 2014" provides data on the Wegeners Granulomatosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wegeners Granulomatosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wegeners Granulomatosis. This report is built using data and information sourced from proprietary
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Wiskott-Aldrich Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Wiskott-Aldrich Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Wiskott-Aldrich Syndrome. This report is built using data and information sourced from propriet
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014
X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2014" provides data on the X-Linked Agammaglobulinemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on X-Linked Agammaglobulinemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating X-Linked Agammaglobulinemia. This report is built using data and information source
Published Date: Oct 2014
Published By: GlobalData

Price: $2500
Global and China Naltrexone HCL Industry 2014 Deep Research Report
The report firstly introduced Naltrexone HCL basic information included Naltrexone HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis. Global Regional (such as US Europe Asia China Japan etc regions) Global Leading Suppliers, different type products, different applications etc Naltrexone HCL production and market share, Naltrexone HCL industry policy and plan, Naltrexone HCL product specification, manufacturing process, product cost structure etc. then statistics Global key manufacturers Naltrexone HCL capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Naltrexone HCL products customers application capac
Published Date: Oct 2014
Published By: QYResearch

Price: $2200
Global and China Nalbuphine HCL Industry 2014 Deep Research Report
The report firstly introduced Nalbuphine HCL basic information included Nalbuphine HCL definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Nalbuphine HCL industry policy and plan, Nalbuphine HCL product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Nalbuphine HCL capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Nalbuphine HCL products customers application capacity market position company contact information etc company related information, then collect all these
Published Date: Oct 2014
Published By: QYResearch

Price: $2200
Depression - Pipeline Review, H2 2014
Global Markets Directs, Depression Pipeline Review, H2 2014, provides an overview of the Depressions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Depression and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information source
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Wounds - Pipeline Review, H2 2014
Global Markets Directs, Wounds Pipeline Review, H2 2014, provides an overview of the Woundss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wounds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Wounds and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Market
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2014
Global Markets Directs, Congestive Heart Failure (Heart Failure) Pipeline Review, H2 2014, provides an overview of the Congestive Heart Failure (Heart Failure)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Congestive Heart Failure (Heart Failure), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Congestive Heart Failure (Heart Failure) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from acr
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Age Related Macular Degeneration - Pipeline Review, H2 2014
Global Markets Directs, Age Related Macular Degeneration Pipeline Review, H2 2014, provides an overview of the Age Related Macular Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Age Related Macular Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Age Related Macular Degeneration and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy a
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Cystic Fibrosis - Pipeline Review, H2 2014
Global Markets Directs, Cystic Fibrosis Pipeline Review, H2 2014, provides an overview of the Cystic Fibrosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cystic Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cystic Fibrosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Traumatic Brain Injury - Pipeline Review, H2 2014
Global Markets Directs, Traumatic Brain Injury Pipeline Review, H2 2014, provides an overview of the Traumatic Brain Injurys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Traumatic Brain Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traumatic Brain Injury and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Sepsis - Pipeline Review, H2 2014
Global Markets Directs, Sepsis Pipeline Review, H2 2014, provides an overview of the Sepsiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sepsis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sepsis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Market
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Pulmonary Arterial Hypertension - Pipeline Review, H2 2014
Global Markets Directs, Pulmonary Arterial Hypertension Pipeline Review, H2 2014, provides an overview of the Pulmonary Arterial Hypertensions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pulmonary Arterial Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pulmonary Arterial Hypertension and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Ischemia Reperfusion Injury - Pipeline Review, H2 2014
Global Markets Directs, Ischemia Reperfusion Injury Pipeline Review, H2 2014, provides an overview of the Ischemia Reperfusion Injurys therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ischemia Reperfusion Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemia Reperfusion Injury and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,00
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Liver Fibrosis - Pipeline Review, H2 2014
Global Markets Directs, Liver Fibrosis Pipeline Review, H2 2014, provides an overview of the Liver Fibrosiss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Liver Fibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Liver Fibrosis and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Hyperlipidemia - Pipeline Review, H2 2014
Global Markets Directs, Hyperlipidemia Pipeline Review, H2 2014, provides an overview of the Hyperlipidemias therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Hyperlipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hyperlipidemia and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and in
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Ischemic Stroke - Pipeline Review, H2 2014
Global Markets Directs, Ischemic Stroke Pipeline Review, H2 2014, provides an overview of the Ischemic Strokes therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ischemic Stroke, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Ischemic Stroke and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data an
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Sickle Cell Disease - Pipeline Review, H2 2014
Global Markets Directs, Sickle Cell Disease Pipeline Review, H2 2014, provides an overview of the Sickle Cell Diseases therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sickle Cell Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sickle Cell Disease and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is bui
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Diabetic Macular Edema - Pipeline Review, H2 2014
Global Markets Directs, Diabetic Macular Edema Pipeline Review, H2 2014, provides an overview of the Diabetic Macular Edemas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Macular Edema and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The r
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Soft Tissue Sarcoma - Pipeline Review, H2 2014
Global Markets Directs, Soft Tissue Sarcoma Pipeline Review, H2 2014, provides an overview of the Soft Tissue Sarcomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Soft Tissue Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Soft Tissue Sarcoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Alcohol Addiction - Pipeline Review, H2 2014
Global Markets Directs, Alcohol Addiction Pipeline Review, H2 2014, provides an overview of the Alcohol Addictions therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alcohol Addiction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Alcohol Addiction and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2014
Global Markets Directs, Acute Renal Failure (ARF) (Acute Kidney Injury) Pipeline Review, H2 2014, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury) and special features on late-stage and discontinued projects. Global Markets Directs report features invest
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Burns - Pipeline Review, H2 2014
Global Markets Directs, Burns Pipeline Review, H2 2014, provides an overview of the Burnss therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Burns, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Burns and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Di
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Squamous Cell Carcinoma - Pipeline Review, H2 2014
Global Markets Directs, Squamous Cell Carcinoma Pipeline Review, H2 2014, provides an overview of the Squamous Cell Carcinomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Squamous Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Squamous Cell Carcinoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. T
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2014
Global Markets Directs, Systemic Sclerosis (Scleroderma) Pipeline Review, H2 2014, provides an overview of the Systemic Sclerosis (Scleroderma)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy a
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2014
Global Markets Directs, Cutaneous T-Cell Lymphoma Pipeline Review, H2 2014, provides an overview of the Cutaneous T-Cell Lymphomas therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cutaneous T-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Cutaneous T-Cell Lymphoma and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indica
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000
Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, H2 2014
Global Markets Directs, Post-Traumatic Stress Disorder (PTSD) Pipeline Review, H2 2014, provides an overview of the Post-Traumatic Stress Disorder (PTSD)s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Post-Traumatic Stress Disorder (PTSD) and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe coveri
Published Date: Oct 2014
Published By: Global Markets Direct

Price: $2000